Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1264763 | 0.91 | — | — | |
| SCHEMBL2524054 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL6029776 | 0.89 | — | — | |
| SCHEMBL25658968 | 0.84 | SMN1; SMN2 (0.44) | SMN1; SMN2TSHRMAPTFAAHALDH1A1 | |
| SCHEMBL22430280 | 0.81 | TERT (0.37) | SMN1; SMN2TSHRMAPTTERT | |
| SCHEMBL21664183 | 0.81 | TERT (0.37) | SMN1; SMN2TSHRMAPTTERT | |
| SCHEMBL25635380 | 0.79 | SMN1; SMN2 (0.52) | SMN1; SMN2TSHRMAPTFAAHALDH1A1 | |
| SCHEMBL20107210 | 0.79 | TSHR (0.52) | SMN1; SMN2TSHRMAPTFAAHALDH1A1 | |
| SCHEMBL7139864 | 0.78 | — | — | |
| SCHEMBL17841722 | 0.78 | TSHR (0.60) | SMN1; SMN2TSHRMAPTFAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3141615-B1 | REAL-TIME NUCLEIC ACID DETECTION PROCESSES AND COMPOSITIONS | ENZO LIFE SCIENCES INC (US) | 2019-10-23 | — | — | EP | disclosed |
| EP-1348713-B1 | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | ENZO LIFE SCIENCES INC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-10144956-B2 | Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids | ENZO BIOCHEM, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| EP-2366798-B1 | Nucleic acid detection process involving energy transfer labels on nucleotide | ENZO LIFE SCIENCES INC (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-1344835-B1 | REAL-TIME NUCLEIC ACID DETECTION PROCESSES AND COMPOSITIONS | ENZO LIFE SCIENCES INC (US) | 2017-06-14 | — | — | EP | disclosed |
| EP-3141615-A1 | REAL-TIME NUCLEIC ACID DETECTION PROCESSES AND COMPOSITIONS | Enzo Life Sciences, Inc. (US) | 2017-03-15 | — | — | EP | disclosed |
| US-9261460-B2 | Real-time nucleic acid detection processes and compositions | ENZO LIFE SCIENCES, INC. (US) | 2016-02-16 | — | — | US | disclosed |
| US-9068948-B2 | Processes for detection of nucleic acids | ENZO LIFE SCIENCES, INC. (US) | 2015-06-30 | — | — | US | disclosed |
| US-20130078640-A1 | PROCESSES FOR DETECTION OF NUCLEIC ACIDS | ENZO LIFE SCIENCES, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-8357793-B2 | Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds | ENZO LIFE SCIENCES, INC. (US) | 2013-01-22 | — | — | US | disclosed |
| US-20060024735-A1 | Chimeric nucleic acid constructs and compositions comprising sets of nucleic acid constructs | ENZO LIFE SCIENCES, INC. (US) | 2006-02-02 | — | — | US | disclosed |
| US-6949659-B2 | Dye labeling composition | ENZO LIFE SCIENCES, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050137388-A1 | Real-time nucleic acid detection processes and compositions | ENZO LIFE SCIENCES, INC. | 2005-06-23 | — | — | US | disclosed |
| US-20050004350-A1 | Novel chemiluminescent reagents | ENZO LIFE SCIENCES, INC. (US) | 2005-01-06 | — | — | US | disclosed |
| US-20040254355-A1 | Labeling reagents comprising aphenylic analogs of rhodamine dyes | ENZO LIFE SCIENCES, INC. | 2004-12-16 | — | — | US | disclosed |
| US-20040229248-A1 | Novel dye labeling composition | ENZO LIFE SCIENCES, INC. | 2004-11-18 | — | — | US | disclosed |
| US-20040230036-A1 | Heterodimeric dye composition | ENZO LIFE SCIENCES, INC. (US) | 2004-11-18 | — | — | US | disclosed |
| US-20030225247-A1 | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | ENZO LIFE SCIENCES, INC. | 2003-12-04 | — | — | US | disclosed |
| EP-1348713-A2 | Labeling reagents and labeled tabeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | Enzo Life Sciences, Inc. (US) | 2003-10-01 | — | — | EP | disclosed |
| EP-1344835-A2 | Real-time nucleic acid detection processes and compositions | Enzo Life Sciences, Inc. (US) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229248-A1 | Novel dye labeling composition | IK, PHAX, CHLSN | SMN1; SMN2 4068/4885TSHR 4649/4885MAPT 1877/4885 |
| US-20050004350-A1 | Novel chemiluminescent reagents | CHLSN, CYBA, HLCS | SMN1; SMN2 4691/4885TSHR 3308/4885MAPT 3811/4885 |
| US-20040230036-A1 | Heterodimeric dye composition | IK, CHLSN, CRY2 | SMN1; SMN2 4246/4885TSHR 4498/4885MAPT 2375/4885 |
| US-20030225247-A1 | Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses | POLRMT, CHLSN, PHAX | SMN1; SMN2 3730/4885TSHR 3683/4885MAPT 2080/4885 |
| US-20040254355-A1 | Labeling reagents comprising aphenylic analogs of rhodamine dyes | IK, RBM25, CHLSN | SMN1; SMN2 4694/4885TSHR 3063/4885MAPT 2363/4885 |
| US-20050137388-A1 | Real-time nucleic acid detection processes and compositions | POLRMT, DNTT, RNGTT | SMN1; SMN2 2072/4885TSHR 3756/4885MAPT 1437/4885 |
| US-20060024735-A1 | Chimeric nucleic acid constructs and compositions comprising sets of nucleic acid constructs | DNTT, RNGTT, POLRMT | SMN1; SMN2 1539/4885TSHR 3964/4885MAPT 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.